OpenURL Connection Search

Select item for more details and to access through your institution.

Magnetic resonance imaging and neuropsychological results from a trial of memantine in Alzheimer’s disease
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2011, v. 7, n. 4, p. 425, doi. 10.1016/j.jalz.2010.09.003
By:
- Weiner, Michael W.;
- Sadowsky, Carl;
- Saxton, Judith;
- Hofbauer, Robert K.;
- Graham, Stephen M.;
- Yu, Sung Yun;
- Li, Shaoyi;
- Hsu, Hai-An;
- Suhy, Joyce;
- Fridman, Moshe;
- Perhach, James L.
Publication type:
Article
Effects of memantine on functional communication in patients with moderate AD: Results of a 12-week placebo-controlled trial
Published in:
2009
By:
- Hofbauer, Robert K.;
- Saxton, Judith;
- Woodward, Michael;
- Gilchrist, Nigel;
- Potocnik, Felix;
- Yu, Sung Yun;
- Hsu, Hai-An;
- Graham, Stephen M.;
- Perhach, James L.
Publication type:
Abstract
Patient-reported migraine-specific quality of life, activity impairment and headache impact with once-daily atogepant for preventive treatment of migraine in a randomized, 52-week trial.
Published in:
Cephalalgia, 2023, v. 43, n. 9, p. 1, doi. 10.1177/03331024231190296
By:
- Lipton, Richard B.;
- Halker Singh, Rashmi B.;
- Mechtler, Laszlo;
- McVige, Jennifer;
- Ma, Julia;
- Yu, Sung Yun;
- Stokes, Jonathan;
- Dabruzzo, Brett;
- Gandhi, Pranav;
- Ashina, Messoud
Publication type:
Article
Safety and efficacy of ubrogepant in participants with major cardiovascular risk factors in two single-attack phase 3 randomized trials: ACHIEVE I and II.
Published in:
Cephalalgia, 2021, v. 41, n. 9, p. 979, doi. 10.1177/03331024211000311
By:
- Hutchinson, Susan;
- Silberstein, Stephen D;
- Blumenfeld, Andrew M;
- Lipton, Richard B;
- Lu, Kaifeng;
- Yu, Sung Yun;
- Severt, Lawrence
Publication type:
Article
Safety and efficacy of ubrogepant for the acute treatment of perimenstrual migraine attacks: A post hoc analysis.
Published in:
Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 8, p. 1135, doi. 10.1111/head.14619
By:
- MacGregor, E. Anne;
- Hutchinson, Susan;
- Lai, Hongxin;
- Dabruzzo, Brett;
- Yu, Sung Yun;
- Trugman, Joel M.;
- Ailani, Jessica
Publication type:
Article
Ubrogepant, an Acute Treatment for Migraine, Improved Patient‐Reported Functional Disability and Satisfaction in 2 Single‐Attack Phase 3 Randomized Trials, ACHIEVE I and II.
Published in:
Headache: The Journal of Head & Face Pain, 2020, v. 60, n. 4, p. 686, doi. 10.1111/head.13766
By:
- Dodick, David W.;
- Lipton, Richard B.;
- Ailani, Jessica;
- Halker Singh, Rashmi B.;
- Shewale, Anand R.;
- Zhao, Sihui;
- Trugman, Joel M.;
- Yu, Sung Yun;
- Viswanathan, Hema N.
Publication type:
Article
Long‐Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52‐Week Extension Trial.
Published in:
Headache: The Journal of Head & Face Pain, 2020, v. 60, n. 1, p. 141, doi. 10.1111/head.13682
By:
- Ailani, Jessica;
- Lipton, Richard B.;
- Hutchinson, Susan;
- Knievel, Kerry;
- Lu, Kaifeng;
- Butler, Matthew;
- Yu, Sung Yun;
- Finnegan, Michelle;
- Severt, Lawrence;
- Trugman, Joel M.
Publication type:
Article
Ubrogepant for the Acute Treatment of Migraine: Pooled Efficacy, Safety, and Tolerability From the ACHIEVE I and ACHIEVE II Phase 3 Randomized Trials.
Published in:
Neurology & Therapy, 2021, v. 10, n. 1, p. 235, doi. 10.1007/s40120-021-00234-7
By:
- Hutchinson, Susan;
- Dodick, David W.;
- Treppendahl, Christina;
- Bennett, Nathan L.;
- Yu, Sung Yun;
- Guo, Hua;
- Trugman, Joel M.
Publication type:
Article

Found: 8